TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BerGenBio ASA ( (BRRGF) ) just unveiled an update.
Oncoinvent ASA has completed a fully underwritten rights issue, resulting in the allocation of 260,000,000 new shares to various primary insiders and their close associates. This significant capital raise is contingent upon approval at an extraordinary general meeting and is subject to regulatory disclosure requirements.
The most recent analyst rating on (BRRGF) stock is a Buy with a NOK38.00 price target. To see the full list of analyst forecasts on BerGenBio ASA stock, see the BRRGF Stock Forecast page.
More about BerGenBio ASA
Average Trading Volume: 443,119
Current Market Cap: NOK208.3M
For an in-depth examination of BRRGF stock, go to TipRanks’ Overview page.